Literature DB >> 18971376

The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival.

Elizabeth Vafiadaki1, Demetrios A Arvanitis, Stamatis N Pagakis, Vasiliki Papalouka, Despina Sanoudou, Aikaterini Kontrogianni-Konstantopoulos, Evangelia G Kranias.   

Abstract

Cardiac contractility is regulated through the activity of various key Ca(2+)-handling proteins. The sarco(endo)plasmic reticulum (SR) Ca(2+) transport ATPase (SERCA2a) and its inhibitor phospholamban (PLN) control the uptake of Ca(2+) by SR membranes during relaxation. Recently, the antiapoptotic HS-1-associated protein X-1 (HAX-1) was identified as a binding partner of PLN, and this interaction was postulated to regulate cell apoptosis. In the current study, we determined that HAX-1 can also bind to SERCA2. Deletion mapping analysis demonstrated that amino acid residues 575-594 of SERCA2's nucleotide binding domain are required for its interaction with the C-terminal domain of HAX-1, containing amino acids 203-245. In transiently cotransfected human embryonic kidney 293 cells, recombinant SERCA2 was specifically targeted to the ER, whereas HAX-1 selectively concentrated at mitochondria. On triple transfections with PLN, however, HAX-1 massively translocated to the ER membranes, where it codistributed with PLN and SERCA2. Overexpression of SERCA2 abrogated the protective effects of HAX-1 on cell survival, after hypoxia/reoxygenation or thapsigargin treatment. Importantly, HAX-1 overexpression was associated with down-regulation of SERCA2 expression levels, resulting in significant reduction of apparent ER Ca(2+) levels. These findings suggest that HAX-1 may promote cell survival through modulation of SERCA2 protein levels and thus ER Ca(2+) stores.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971376      PMCID: PMC2613088          DOI: 10.1091/mbc.e08-06-0587

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  66 in total

1.  Multiple effects of SERCA2b mutations associated with Darier's disease.

Authors:  Wooin Ahn; Min Goo Lee; Kyung Hwan Kim; Shmuel Muallem
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

Review 2.  Calcium cycling in congestive heart failure.

Authors:  Gerd Hasenfuss; Burkert Pieske
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

3.  Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.

Authors:  Joachim P Schmitt; Mitsuhiro Kamisago; Michio Asahi; Guo Hua Li; Ferhaan Ahmad; Ulrike Mende; Evangelia G Kranias; David H MacLennan; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

4.  Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.

Authors:  Leonard Dode; Jens Peter Andersen; Natalie Leslie; Jittima Dhitavat; Bente Vilsen; Alain Hovnanian
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

Review 5.  Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure.

Authors:  Michio Asahi; Hiroyuki Nakayama; Michihiko Tada; Kinya Otsu
Journal:  Trends Cardiovasc Med       Date:  2003-05       Impact factor: 6.677

6.  Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors.

Authors:  Chi Li; Casey J Fox; Stephen R Master; Vytautas P Bindokas; Lewis A Chodosh; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

7.  Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.

Authors:  Kobra Haghighi; Fotis Kolokathis; Luke Pater; Roy A Lynch; Michio Asahi; Anthony O Gramolini; Guo-Chang Fan; Dimitris Tsiapras; Harvey S Hahn; Stamatis Adamopoulos; Stephen B Liggett; Gerald W Dorn; David H MacLennan; Dimitrios T Kremastinos; Evangelia G Kranias
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Obscurin is a ligand for small ankyrin 1 in skeletal muscle.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Ellene M Jones; Damian B Van Rossum; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

9.  Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.

Authors:  Chikashi Toyoshima; Michio Asahi; Yuji Sugita; Reena Khanna; Takeo Tsuda; David H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

10.  BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis.

Authors:  Luca Scorrano; Scott A Oakes; Joseph T Opferman; Emily H Cheng; Mia D Sorcinelli; Tullio Pozzan; Stanley J Korsmeyer
Journal:  Science       Date:  2003-03-06       Impact factor: 47.728

View more
  47 in total

1.  Recruitment of pro-IL-1α to mitochondrial cardiolipin, via shared LC3 binding domain, inhibits mitophagy and drives maximal NLRP3 activation.

Authors:  Jargalsaikhan Dagvadorj; Karolina Mikulska-Ruminska; Gantsetseg Tumurkhuu; Rojo A Ratsimandresy; Jessica Carriere; Allen M Andres; Stefanie Marek-Iannucci; Yang Song; Shuang Chen; Malcolm Lane; Andrea Dorfleutner; Roberta A Gottlieb; Christian Stehlik; Suzanne Cassel; Fayyaz S Sutterwala; Ivet Bahar; Timothy R Crother; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

2.  Digenic mutations in severe congenital neutropenia.

Authors:  Manuela Germeshausen; Cornelia Zeidler; Manfred Stuhrmann; Marina Lanciotti; Matthias Ballmaier; Karl Welte
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

3.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

4.  Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region.

Authors:  Erik K Larsen; Daniel K Weber; Songlin Wang; Tata Gopinath; Daniel J Blackwell; Michael P Dalton; Seth L Robia; Jiali Gao; Gianluigi Veglia
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-08-07       Impact factor: 3.747

Review 5.  SERCA control of cell death and survival.

Authors:  Elie R Chemaly; Luca Troncone; Djamel Lebeche
Journal:  Cell Calcium       Date:  2017-07-12       Impact factor: 6.817

6.  Heat-shock proteins attenuate SERCA inactivation by the anti-apoptotic protein Bcl-2: possible implications for the ER Ca2+-mediated apoptosis.

Authors:  Elena S Dremina; Victor S Sharov; Christian Schöneich
Journal:  Biochem J       Date:  2012-05-15       Impact factor: 3.857

7.  Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Christopher J Froelich; Simon C Watkins; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

8.  Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer.

Authors:  Daniel J Blackwell; Taylor J Zak; Seth L Robia
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

Review 9.  The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus.

Authors:  Ilse Vandecaetsbeek; Peter Vangheluwe; Luc Raeymaekers; Frank Wuytack; Jo Vanoevelen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

Review 10.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.